Jones J E, Nelson E A
Cochrane Database Syst Rev. 2007 Apr 18(2):CD001737. doi: 10.1002/14651858.CD001737.pub3.
Venous leg ulceration is a recurrent, chronic, disabling condition. It affects up to one in 100 adults at some time. Standard treatments are simple dressings and compression bandages or stockings. Sometimes, despite treatment, ulcers remain open for months or years. Sometimes skin grafts are used to stimulate healing. These may be taken, or grown into a dressing, from the patient's own uninjured skin (autografts), or applied as a sheet of bioengineered skin grown from donor cells (allograft). Preserved skin from other animals, such as pigs, has also been used (xenografts).
To assess the effect of skin grafts for treating venous leg ulcers.
We searched the Cochrane Wounds Group Specialised Register (February 2006) and the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 1, 2006).
Randomised controlled trials (RCTs) of skin grafts in the treatment of venous leg ulcers.
Two reviewers independently undertook data extraction and assessment of study quality.
We identified 15 trials - generally of poor methodological quality - involving 768 participants. In 11 trials participants also received compression bandaging. One trial (31 participants) compared a dressing with an autograft. Three trials (74 participants) compared frozen allografts with dressings, and three trials (47 participants) compared fresh allografts with dressings. Two trials (345 participants) compared tissue-engineered skin (bilayer artificial skin) with a dressing. In two trials (71 participants) a single-layer dermal replacement was compared with standard care. Four trials compared skin grafting techniques: one trial (92 participants) compared autografts with frozen allograft, a second (51 participants) compared a pinch graft (autograft) with a porcine dermis (xenograft), the third (seven participants, 12 ulcers) compared tissue-engineered skin with a split-thickness graft, the fourth (10 participants) compared a fresh allograft with a frozen allograft. The trials comparing bilayer artificial skin with a dressing reported a significantly higher proportion of ulcers healing with artificial skin. There was not enough evidence from the other trials to determine whether other types of skin grafting increased the healing of venous ulcers.
AUTHORS' CONCLUSIONS: Bilayer artificial skin, used in conjunction with compression bandaging, increases the chance of healing a venous ulcer compared with compression and a simple dressing. Further research is needed to assess whether other forms of skin grafts increase ulcer healing.
下肢静脉溃疡是一种复发性、慢性、致残性疾病。在某些时候,每100名成年人中就有1人会受到影响。标准治疗方法是简单的敷料以及加压绷带或弹力袜。有时,尽管进行了治疗,溃疡仍会持续数月或数年不愈合。有时会使用皮肤移植来促进愈合。这些移植皮肤可以取自患者自身未受伤的皮肤(自体移植),也可以在敷料中生长而成,或者应用由供体细胞培育而成的生物工程皮肤片(异体移植)。其他动物(如猪)的保存皮肤也被使用过(异种移植)。
评估皮肤移植治疗下肢静脉溃疡的效果。
我们检索了Cochrane伤口小组专业注册库(2006年2月)和Cochrane对照试验中央注册库(《Cochrane图书馆》,2006年第1期)。
皮肤移植治疗下肢静脉溃疡的随机对照试验(RCT)。
两名评价员独立进行数据提取和研究质量评估。
我们确定了15项试验——总体方法学质量较差——涉及768名参与者。在11项试验中,参与者还接受了加压绷带治疗。一项试验(31名参与者)比较了一种敷料与自体移植。三项试验(74名参与者)比较了冷冻异体移植与敷料,三项试验(47名参与者)比较了新鲜异体移植与敷料。两项试验(345名参与者)比较了组织工程皮肤(双层人工皮肤)与敷料。两项试验(71名参与者)比较了单层真皮替代物与标准护理。四项试验比较了皮肤移植技术:一项试验(92名参与者)比较了自体移植与冷冻异体移植,第二项试验(51名参与者)比较了点状移植(自体移植)与猪真皮(异种移植),第三项试验(7名参与者,12处溃疡)比较了组织工程皮肤与断层皮片移植,第四项试验(10名参与者)比较了新鲜异体移植与冷冻异体移植。比较双层人工皮肤与敷料的试验报告称,使用人工皮肤愈合的溃疡比例显著更高。其他试验没有足够的证据来确定其他类型的皮肤移植是否能促进下肢静脉溃疡的愈合。
与加压和简单敷料相比,双层人工皮肤联合加压绷带可增加下肢静脉溃疡愈合的机会。需要进一步研究来评估其他形式的皮肤移植是否能促进溃疡愈合。